PubMed Health⌕ Search

Biomedical subjects

A Elkouby

Publications and source records attributed to A Elkouby.

26 records · Page 2Linked to original sources

Comparison of high-affinity binding of [3H]GABA to subcellular particles of rat brain and liver.

The binding of [3H]GABA and retention of [14C]sucrose have been studied in freshly prepared "synaptosomal-mitochondrial" (P2) fractions of rat cerebral cortex and liver using bicarbonate-buffered medium (containing 147 mEq/liter of Na+), and in frozen/thawed crude membrane fractions of rat whole brain and liver using Na+-free Tris HCl medium. GABA-sensitive sites (GSS) and bicuculline-methiodide- (BMI-) sensitive sites (BMI-SS) were defined as those amounts of [3H]GABA that were sensitive to the displacement by 10(-3) M unlabeled GABA or BMI. In the presence of added Na+, two high-affinity GABA-binding processes were detected in the P2 fraction of cerebral cortex. The lower-affinity process (likely related mainly to uptake sites) had KB approximately equal to 10(-5) M, Bmax for GSS approximately equal to 3 nmol/mg protein, and Bmax for BMI-SS approximately equal to 0.5 nmol/mg protein, whereas the higher-affinity process (likely related to synaptic GABA receptors) had KB approximately equal to 10(-7) M, BMAX for GSS approximately equal to 43 pmol/mg protein, and BMAX for BMI-SS approximately equal to 2 pmol/mg proteins. Only the higher-affinity process was detected in the liver P2 fraction, and it had KB approximately equal to 3.7 x 10(-8) M, BMAX for GSS approximately equal to 0.48 pmol/mg protein, and BMAX for BMI-SS approximately equal to 0.1 pmol/mg protein (i.e., about 1/100 and 1/20 the receptive BMAX values of cerebral cortex). This binding process of the liver P2 fraction could represent sites involved in mitochondrial GABA transport. In Na+-free Tris HCl medium, high-affinity [3H]GABA binding appeared to exist in frozen/thawed membrane preparations of both brain and liver when data were expressed on a protein basis. However, this binding to liver membranes was not displaceable by 10(-5) M unlabeled GABA, and when these data were expressed on a weight basis and corrected for [3H]GABA present in trapped supernatant fluid of the pellets, no [3H]GABA binding was detected in the liver preparation.

Animals↗

Modifications of platelet shape change and ATP release during cardiopulmonary bypass.

Platelet activation is accompanied by characteristic morphological changes: smooth-disc platelets become more spherical in shape and develop psudopods. The purpose of this study is to investigate whether platelets change after extracorporeal bypass. Twenty-two patients undergoing cardiopulmonary bypass (CPB) were studied prior to anesthesia and immediately after the operation. Platelets activated by different agonists were monitored simultaneously for morphological changes, ATP release and aggregation. While shape change measured before surgery was large, it was significantly reduced after bypass surgery (p < 0.01); morphological changes were quicker postoperatively. Several other parameters also changed: the time lapse between administration of the agonist and the start of ATP secretion decrease significantly (p < 0.01). After activation with high concentrations of ADP, ATP release was significantly increased (p < 0.01). On the other hand, less ATP was released after platelet activation with collagen and arachidonic acid, suggesting a change in platelet adhesion or a downregulation of endoperoxide synthesis. In our study, the importance of preactivation change in shape, estimated quantitatively by percent loss in ability of changing shape, can be compared using various agonists, with proportional defects in release and aggregation. These data provide evidence for different intrinsic levels in platelet defects after CPB.

Adenosine Diphosphate↗